• linkedin
  • Increase Font
  • Sharebar

    Ribbon rejuvenation

    Study ranks surgeon and patient experience with next generation facial suspension device

    123


    Dr. Apfelberg
    PALO ALTO, CALIF. — The technology to attain lower-face rejuvenation continues to evolve, with patients and surgeons alike demanding better devices and techniques to yield longer-lasting results — all while the minimally invasive ante continues to be raised by patient lifestyles and perceptions of downtime and recovery. According to one firm's medical advisory board chair, the Endotine Ribbon (Coapt Systems, Inc.; Palo Alto, Calif.) delivers just that, as it offers longer-lasting lower face and neck lifts, and can sculpt the jawline with ease and predictability. David Apfelberg, M.D., assistant clinical professor of plastic surgery at Stanford University Medical Center, Palo Alto, Calif., and chairman of the Medical Advisory Board of Coapt Systems, tells Cosmetic Surgery Times that "the Endotine Ribbon is a new device we designed that can be used minimally invasively, and is optimally effective in younger patients, say, between 30 and 50 years of age. The device imparts an unprecedented flexibility with a variety of surgical approaches, lift vectors, degrees of lift and is very easy to use."

    SURGEON SATISFACTION Coapt Systems conducted a multicenter, multispecialty study involving eight surgeons who implanted the Endotine Ribbon device in the neck, jowl, upper face, midface or in combination, in a total of 41 patients, fixating the soft tissue in this facelift procedure. Follow-up was conducted at 30, 60 and 90 days, post-procedure. Thirty-two patients completed the study at 90 days and 10 patients were lost to follow-up. Immediately following the procedure, surgeons were asked to rate their experience using the device and rate the satisfaction of the results and of the device. During the follow-up visits, physicians were required to record the ongoing performance of the device by rating the visibility, palpability and elevation of tissue, as well as the patient's skin sensitivity and satisfaction with their appearance.


    34-year-old female patient shown before (left) and approximately 10 weeks after (right) minimally invasive placement of Ribbon device in cheeks/jowl and neck. (Photo credit: Jason Diamond, M.D.)
    Immediately following the procedure, 100 percent of the surgeons rated the device as very satisfactory/satisfactory, regarding the ease of device deployment, anchoring, inserting, adjusting and leash trimming. The device received a 98 percent very satisfactory/satisfactory rating regarding engaging and elevating the tissue. Further results showed that 93 percent of physicians (38/41) rated the visibility of the device under the skin as not visible/slightly visible, and 89 percent (36/41) rated the Ribbon as not palpable/slightly palpable. Tissue elevation was maintained in all patients at the 90-day follow-up, and the patients' sensitivity and device visibility were rated at 94 percent. The device was rated as nonpalpable/slightly palpable in 27 out of the 32 patients (84 percent). Overall, the physicians rated the product performance satisfaction at 91 percent.

    "The Ribbon is actually a true surgical procedure, although it's minimally invasive," Dr. Apfelberg explains. "After making small incisions, you dissect a flap and then deploy the Ribbon in the supporting structures, such as the platysma in the neck or the SMAS fascia in the cheek. It can very effectively elevate and hold these tissues long term."

    Dr. Apfelberg expects the Ribbon's results to be considerably more permanent than those of Contour Threads and other thread lifts.

    123

    Poll